(Q51548625)

6 April 2018

title

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor. (English)

1 reference

6 April 2018

0 references

1 reference

2

Jian Zhang

1 reference

6 April 2018

author name string

Yi Lu

1

1 reference

6 April 2018

Jinlu Dai

3

1 reference

6 April 2018

Lindsay A Dehne

4

1 reference

6 April 2018

Atsushi Mizokami

5

1 reference

6 April 2018

Zhi Yao

6

1 reference

6 April 2018

Evan T Keller

7

1 reference

6 April 2018

publication date

1 January 2004

1 reference

6 April 2018

Clinical & Experimental Metastasis

published in

1 reference

6 April 2018

volume

21

1 reference

6 April 2018

page(s)

399-408

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s10585-005-0056-6

exact match

0 references

cites work

Generalised increase in bone resorption in carcinoma of the prostate

1 reference

12 December 2020

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

1 reference

12 December 2020

Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation

1 reference

12 December 2020

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

1 reference

12 December 2020

Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate

1 reference

12 December 2020

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

1 reference

12 December 2020

Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines

1 reference

12 December 2020

Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.

1 reference

12 December 2020

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

1 reference

12 December 2020

STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

1 reference

12 December 2020

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

1 reference

12 December 2020

Antiandrogen-induced cell death in LNCaP human prostate cancer cells

1 reference

12 December 2020

Steroidal antiandrogens and 5alpha-reductase inhibitors

1 reference

12 December 2020

Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro

1 reference

12 December 2020

The insulin-like growth factor system in the prostate.

1 reference

12 December 2020

The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease

1 reference

12 December 2020

Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.

1 reference

12 December 2020

Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells

1 reference

12 December 2020

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

1 reference

12 December 2020

Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow

1 reference

12 December 2020

Differential expression of osteonectin/SPARC during human prostate cancer progression

1 reference

12 December 2020

Ethanol activates the interleukin-6 promoter in a human bone marrow stromal cell line

1 reference

12 December 2020

Orchiectomy increases bone marrow interleukin-6 levels in mice

1 reference

12 December 2020

Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.

1 reference

12 December 2020

Interleukin-6: a candidate mediator of human prostate cancer morbidity

1 reference

12 December 2020

The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells

1 reference

12 December 2020

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro

1 reference

12 December 2020

Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype

1 reference

12 December 2020

1 reference

12 December 2020

Characterization of the role of IL-6 in the progression of prostate cancer

1 reference

12 December 2020

Insulin-like growth factors and prostate cancer

1 reference

12 December 2020

Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells

1 reference

12 December 2020

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

12 December 2020

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

12 December 2020

Interleukin-6 and prostate cancer progression

1 reference

12 December 2020

Cytokine expression by cultured osteoblasts from patients with osteoporotic fractures.

1 reference

12 December 2020

Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype

1 reference

12 December 2020

Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.

1 reference

12 December 2020

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

1 reference

12 December 2020

VCaP, a cell-based model system of human prostate cancer

1 reference

12 December 2020

Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity

1 reference

12 December 2020

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia

1 reference

12 December 2020

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

12 December 2020

Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.

1 reference

12 December 2020

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

1 reference

12 December 2020

Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.

1 reference

12 December 2020

Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase

1 reference

12 December 2020

10.1007/S10585-005-0056-6

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

15672864

1 reference

6 April 2018